Zhihong Yang - Concepedia

Author

Zhihong Yang

Dana-Farber Cancer Institute

Also Known As

Z Yang, Z. Yang, Z., Yang, ZHIHONG YANG, Zhi-Hong Yang, Zhihong Yang

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Mayo Clinic in Arizona Tennessee Oncology Sarah Cannon Shanghai Jiao Tong University

About

Zhihong Yang is an author at Dana-Farber Cancer Institute specializing in developmental biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	400
2	Cell Biology	3	3	400
3	Health Sciences	1	1	292
4	Natural Sciences	1	1	98
5	Public Health	1	1	10

Zhihong Yang

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma Noopur Raje, Jesús G. Berdeja, Yi Lin, New England Journal of Medicine	2019	1.7K
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma Paula Rodríguez‐Otero, Sikander Ailawadhi, Bertrand Arnulf, New England Journal of Medicine	2023	627
Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study Zhihong Yang, Jiaen Liu, Gary S. Collins, Molecular Cytogenetics	2012	548
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Blood	2018	478
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Leukemia	2018	440
Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination Hugo C. Olguín, Zhihong Yang, Stephen J. Tapscott, The Journal of Cell Biology Muscle FunctionCytoskeletonCellular PhysiologyReciprocal InhibitionMuscle Physiology	2007	292
High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma Anjan Thakurta, María Ortiz, Pedro Blecua, Blood	2019	111
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial Yi Lin, Noopur Raje, Jesús G. Berdeja, Nature Medicine	2023	106
Selection of competent blastocysts for transfer by combining time-lapse monitoring and array CGH testing for patients undergoing preimplantation genetic screening: a prospective study with sibling oocytes Zhihong Yang, John H. Zhang, Shala A Salem, BMC Medical Genomics	2014	102
MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state Zhihong Yang, Kyle L. MacQuarrie, Erwin Analau, Genes & Development Molecular RegulationMolecular BiologyMyod HeterodimersCytoskeletonCellular Physiology	2009	98

Page 1